News | August 11, 2009

T-Wave Morphology Opens New Door to Cardiovascular Mortality Prognosis

August 11, 2009 – New research reveals T-wave morphology parameters contain predictive value for mortality in the general population, independent of other clinical risk factors, according to a study published in the August issue of the HeartRhythm Journal, the official journal of the Heart Rhythm Society.

The study indicates T-wave morphology parameters may allow healthcare professionals to better assess arrhythmia vulnerability in patients, and the prognostic value is uniquely related to cardiovascular mortality and seems to be gender specific. The study, led by Kimmo Porthan, M.D., department of cardiology at Helsinki University Central Hospital in Finland, aims to equip health professionals with a dependable prognosis tool that has never been available through traditional electrocardiographic QT intervals. The study was the largest of its kind and conducted by assessing 5,917 adults participating in the Finnish population-based Health 2000 Study.

“The study shows that, unlike ECG QT intervals, T-wave morphology parameters contain predictive value for mortality in the general population,” said Dr. Porthan. “The study results deepen our existing knowledge about the predictive value of several ECG repolarization parameters and will potentially help plan future clinical trials assessing cardiac repolarization.”

In this large, population-based prospective study, ECG T-wave morphology parameters, but not heart rate-corrected QT interval, provide independent prognostic information specifically on cardiovascular mortality. Of the 335 deaths that occurred between the start of the study and a mean follow-up of nearly six years, 131 were cardiovascular deaths. Additionally, T-wave morphology parameters show gender specificity in their performance, suggesting that T-wave morphology parameters should be assessed gender specifically in order for clinical risk indicators to be as precise as possible.

T-wave morphology parameters measure abnormalities during the ventricular repolarization phase and are potentially interrelated with arrhythmia vulnerability. As researchers learn more, T-wave morphology parameters may eventually help health professionals select specific treatment strategies.

For more information: www.heartrhythmjournal.com

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG| August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Overlay Init